Atalaya Capital Management’s Arbor Rapha Capital Bioholdings Corp. I Units ARCKU Stock Holding History

Atalaya Capital Management’s Portfolio ARCKU Stock Details ARCKU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-350,000	Closed	-$3.54M	–	444
2022 Q2	$3.54M	Hold	350,000	–	–	0.42%	75
2022 Q1	$3.52M	Hold	350,000	–	–	0.38%	79
2021 Q4	$3.55M	Buy	+350,000	New	+$3.54M	0.35%	77

Other funds holding ARCKU

HIM

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.76% 1-Year Est. Return

CCA

Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.34% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.95% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CCM

Condor Capital Management Martinsville, New Jersey $1.2B AUM 13.18% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Atalaya Capital Management's ARCKU Position: Q3 2022 in Review

Atalaya Capital Management sold out of Arbor Rapha Capital Bioholdings Corp. I Units (ARCKU) in Q3 2022, closing a stake of 350,000 shares — an estimated $3.54M sold.

Atalaya Capital Management first reported a position in ARCKU in Q4 2021 and held it in 3 quarters. The position peaked at $3.55M in Q4 2021. 13 funds tracked by Wall St. Rank hold ARCKU as of Q3 2022.

Atalaya Capital Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Units position as of Q3 2022 after selling out during the quarter.
Atalaya Capital Management sold 350,000 Arbor Rapha Capital Bioholdings Corp. I Units shares in Q3 2022, an estimated $3.54M.
Atalaya Capital Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Units in Q4 2021 and held it in 3 quarters.
Atalaya Capital Management's Arbor Rapha Capital Bioholdings Corp. I Units position peaked at $3.55M in Q4 2021.
13 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Units as of Q3 2022.

Based on Atalaya Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.